Herbalife Reports Second Straight Year Of Record Sales And Of Costs Climbing Due To Pandemic
Executive Summary
Herbalife’s Asia-Pacific region led 2021 sales growth even as China sales continued to slide despite initiatives to boost business there. It reported record sales levels despite limits due to COVID-19 pandemic on shopping and other consumer activity while pandemic continues impacting supply and shipping costs and influenced 2022 earnings forecast.
You may also be interested in...
USANA’s Preliminary Earnings Alert Could Signal Trend In Q2 Results Across Consumer Health
Pandemic-related market lockdowns, shipping backlogs and other disruptions in mainland China and other countries USANA referenced in announcement also could affect results for its direct-selling competitors as well as other firms in health, wellness, personal care and beauty industries.
Herbalife Expects In-Person Events Will Spur Results From ‘Pandemic Cohort’ Of Distributors
Herbalife reported $1.3bn net sales in latest quarter, 11% off previous year on lack of in-person sales experiences from distributors recruited during pandemic.
US Q1 Consumer Health Earnings Preview: Pivoting From Planning Changes To Parsing Results
Inflation's impact on consumer spending will be front and center in sector’s quarterly reports, beginning with J&J on 19 April. Potential impact also from price hikes common from most firms since early 2021 in response to increasing costs. Russia’s invasion of Ukraine also will prompt comment.